NCT03464175

Brief Summary

The intention is to enroll a specific sample of intubated patients. To compare the effect of respiratory gas conditioning on lung deposition and considering the well-known influences of lung pathology on lung deposition, intubated patients with healthy lungs will be included. Postoperative neurosurgery ventilated patients respond perfectly to this criteria. A previous study including 17 postoperative neurosurgery patients was performed in 2013 with a perfect collaboration between the ICU and the Department of Neurosurgery and Anesthesiology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 4, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2020

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

2.9 years

First QC Date

March 4, 2018

Last Update Submit

November 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quantity of aerosol deposition from the nebulizer reservoir to the subject. Measured by Planar scintigraphy.

    % of the nominal dose.

    45 minutes

Study Arms (4)

Heated-humidifier left on during nebulization

ACTIVE COMPARATOR
Device: Aerogen Solo®Device: Heated-humidified circuit

Heated-humidifier turned off 30 minutes before nebulization

ACTIVE COMPARATOR
Device: Aerogen Solo®Device: Heated-humidified circuit

Use of a heat and moisture exchanger (HME) filter

ACTIVE COMPARATOR
Device: Aerogen Solo®Device: Conventional dry ventilator circuit with HME filter

Use of a dry ventilator circuit specific for aerosol therapy

ACTIVE COMPARATOR
Device: Aerogen Solo®Device: Dry ventilator circuit specific for aerosol therapy

Interventions

Aerosol particles are generated by a vibrating-mesh nebulizer specifically designed for mechanical ventilation

Heated-humidifier left on during nebulizationHeated-humidifier turned off 30 minutes before nebulizationUse of a dry ventilator circuit specific for aerosol therapyUse of a heat and moisture exchanger (HME) filter

It will be left on during the transfer and the nebulization in group 1

Heated-humidifier left on during nebulization

Streamlined components, specific position for the nebulizer at 30 cm of a V-shaped Y piece

Use of a dry ventilator circuit specific for aerosol therapy

The nebulizer is placed between the filter and the endotracheal tube.

Use of a heat and moisture exchanger (HME) filter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Postoperative neurosurgery intubated patients admitted for brain neurosurgery in the ICU (Intensive care neuro-traumatologic and Toxicologic)- With a healthy lung function.
  • Signed and dated informed consent should be obtained in accordance of local regulations.

You may not qualify if:

  • Spine neurosurgery
  • History of cardiovascular and pulmonary disease
  • Extubation immediately after surgery
  • Modification of the allocated humidification technique before or during the nebulization (heated-humidifier deficiency or safety concern)
  • Inaccurate quantification of aerosol deposition (i.e., artifacts or overlap of tracheal and pulmonary deposition).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universiataires Saint-Luc

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Pierre-François Laterre, MD, PhD

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 4, 2018

First Posted

March 13, 2018

Study Start

January 22, 2018

Primary Completion

December 15, 2020

Study Completion

December 15, 2020

Last Updated

November 4, 2022

Record last verified: 2022-11

Locations